Iron compounds synthesised to combat tuberculosis

A team of researchers from Spain and Latin America have synthesised two iron compounds that inhibit the in vitro growth of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Due their low level of toxicity in mammel cells, the compounds could be used in the future as therapeutic agents and hospital disinfectants...

Read the whole article on

More from